In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Join the founders of Estudio Teddy Cruz + Fonna Forman for a lecture highlighting their dedication to community-engaged research and to the social responsibility of architects and urban planners at ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Join us for this special event with LSE's Philippe Aghion, joint recipient of the 2025 Nobel Memorial Prize in Economic Sciences. This lecture will show how the Schumpeterian growth paradigm can shed ...

The program will consist of a pedagogical series of lectures given over a four-week period, three or four lectures per day, Monday through Friday. The audience will be composed of advanced theoretical ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...